{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:45:35Z","timestamp":1789998335442,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82303168"],"award-info":[{"award-number":["No.82303168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82273038"],"award-info":[{"award-number":["No.82273038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82473292"],"award-info":[{"award-number":["No.82473292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82472936"],"award-info":[{"award-number":["No.82472936"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503303"],"award-info":[{"award-number":["82503303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["No. BK20230736"],"award-info":[{"award-number":["No. BK20230736"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["No. BK20241984"],"award-info":[{"award-number":["No. BK20241984"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gastric cancer (GC) remains a leading cause of cancer-related morbidity and mortality worldwide. Neural invasion (NI) is a common pathological behavior that worsens the prognosis in GC. However, the immune microenvironment of neural invasion-positive GC (NI\n                    <jats:sup>+<\/jats:sup>\n                    GC) and its potential therapeutic implications remain poorly defined. Here, we performed single-cell RNA sequencing (scRNA-seq) on tumor specimens from patients with NI\n                    <jats:sup>+<\/jats:sup>\n                    GC and neural invasion-negative GC (NI\n                    <jats:sup>\u2212<\/jats:sup>\n                    GC) to comprehensively delineate the immune landscape. Our analysis revealed a significant enrichment of exhausted ANXA1\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells within NI\n                    <jats:sup>+<\/jats:sup>\n                    GC tissues, which was validated by flow cytometry and multiplex immunohistochemistry assays. Clinically, patients with greater infiltration of ANXA1\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells had worse overall survival and disease progression. Mechanistically, ANXA1 bound to TRKA via N-terminal region, blocking NEDD4L-mediated ubiquitination and degradation of TRKA, thereby suppressing glycolytic metabolism and driving CD8\u207aT cell exhaustion. Tumor-derived nerve growth factor (NGF) further amplified this exhaustion via TRKA engagement. Importantly, treatment with an ANXA1-derived peptide (A11) combined with TRKA inhibitors synergistically reversed T cell exhaustion and suppressed tumor growth in preclinical models. These findings unveil distinctive features of the immune microenvironment in NI\n                    <jats:sup>+<\/jats:sup>\n                    GC and elucidate the underlying molecular mechanisms of ANXA1\/TRKA axis in facilitating immune evasion, which offer new insights for enhancing the sensitivity of immunotherapy to NI\n                    <jats:sup>+<\/jats:sup>\n                    GC patients.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00444-1","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:34:58Z","timestamp":1775723698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting ANXA1\/TRKA axis enhances immunotherapy sensitivity in neural invasion-positive gastric cancer"],"prefix":"10.1186","volume":"7","author":[{"given":"Tianlu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7636-4451","authenticated-orcid":false,"given":"Yiwen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"3","key":"444_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"444_CR2","doi-asserted-by":"publisher","unstructured":"Cao W, Chen H, Yu Y, Li N, Chen W. Changing profiles of cancer burden worldwide and in china: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783\u201391. https:\/\/doi.org\/10.1097\/CM9.0000000000001474.","DOI":"10.1097\/CM9.0000000000001474"},{"key":"444_CR3","doi-asserted-by":"publisher","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet (London, England). 2020;396(10251):635\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5.","DOI":"10.1016\/S0140-6736(20)31288-5"},{"issue":"18","key":"444_CR4","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1200\/JCO.19.03296","volume":"38","author":"S Fukuoka","year":"2020","unstructured":"Fukuoka S, Hara H, Takahashi N, Kojima T, Kawazoe A, Asayama M, et al. Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase ib trial (REGONIVO, EPOC1603). J Clin Oncol. 2020;38(18):2053\u201361. https:\/\/doi.org\/10.1200\/JCO.19.03296.","journal-title":"J Clin Oncol"},{"key":"444_CR5","doi-asserted-by":"publisher","unstructured":"Kang Y, Boku N, Satoh T, Ryu M, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England). 2017;390(10111):2461\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(17)31827-5.","DOI":"10.1016\/S0140-6736(17)31827-5"},{"issue":"10","key":"444_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc3131","volume":"11","author":"AA Bapat","year":"2011","unstructured":"Bapat AA, Hostetter G, Von Hoff DD, Han H. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer. 2011;11(10):695\u2013707. https:\/\/doi.org\/10.1038\/nrc3131.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"444_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/SLA.0b013e3181fcab8d","volume":"252","author":"GO Ceyhan","year":"2010","unstructured":"Ceyhan GO, Liebl F, Maak M, Schuster T, Becker K, Langer R, et al. The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy. Ann Surg. 2010;252(5):797\u2013804. https:\/\/doi.org\/10.1097\/SLA.0b013e3181fcab8d.","journal-title":"Ann Surg"},{"issue":"1","key":"444_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00805-y","volume":"13","author":"F Cai","year":"2025","unstructured":"Cai F, Gu Y, Ling Y, Yi G, Zang S, Su T, et al. Proteomics in pancreatic cancer. Biomark Res. 2025;13(1):93. https:\/\/doi.org\/10.1186\/s40364-025-00805-y.","journal-title":"Biomark Res"},{"issue":"5","key":"444_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0000000000000968","volume":"260","author":"F Liebl","year":"2014","unstructured":"Liebl F, Demir IE, Mayer K, Schuster T, D\u02bchaese JG, Becker K, et al. The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study. Ann Surg. 2014;260(5):900\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000000968.","journal-title":"Ann Surg"},{"key":"444_CR10","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.2147\/CMAR.S264582","volume":"12","author":"L Chen","year":"2020","unstructured":"Chen L, Lin J, Chen L, Chen Y, Wang X, Guo Z, et al. Perineural invasion and postoperative complications are independent predictors of early recurrence and survival following curative resection of gastric cancer. Cancer Manag Res. 2020;12:7601\u201310. https:\/\/doi.org\/10.2147\/CMAR.S264582.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"444_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2023.2257785","volume":"36","author":"L Wang","year":"2023","unstructured":"Wang L, Xia Y, Jiang T, Li Y, Shen Y, Lin J, et al. Neural invasion is an independent prognostic factor in young and lymph node negative gastric cancer patients underwent curative gastrectomy. J Invest Surg. 2023;36(1):2257785. https:\/\/doi.org\/10.1080\/08941939.2023.2257785.","journal-title":"J Invest Surg"},{"issue":"3","key":"444_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"issue":"8","key":"444_CR13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley D, Moncada R, Pour M, Liberman DA, Dryg I, Werba G, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022;54(8):1192\u2013201. https:\/\/doi.org\/10.1038\/s41588-022-01141-9.","journal-title":"Nat Genet"},{"issue":"11","key":"444_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"issue":"1","key":"444_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2019.05.003","volume":"75","author":"ML Suv\u00e0","year":"2019","unstructured":"Suv\u00e0 ML, Tirosh I. Single-cell RNA sequencing in cancer: lessons learned and emerging challenges. Mol Cell. 2019;75(1):7\u201312. https:\/\/doi.org\/10.1016\/j.molcel.2019.05.003.","journal-title":"Mol Cell"},{"key":"444_CR16","doi-asserted-by":"publisher","unstructured":"Potter SS. Single-cell RNA sequencing for the study of development, physiology and disease. Nat Rev Nephrol. 2018;14(8):479\u201392. https:\/\/doi.org\/10.1038\/s41581-018-0021-7.","DOI":"10.1038\/s41581-018-0021-7"},{"issue":"2","key":"444_CR17","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12(2):620\u201338. https:\/\/doi.org\/10.7150\/thno.60540.","journal-title":"Theranostics"},{"issue":"3","key":"444_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 2022;12(3):670\u201391. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0683.","journal-title":"Cancer Discov"},{"issue":"1","key":"444_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32627-z","volume":"13","author":"K Sun","year":"2022","unstructured":"Sun K, Xu R, Ma F, Yang N, Li Y, Sun X, et al. ScRNA-seq of gastric tumor shows complex intercellular interaction with an alternative t cell exhaustion trajectory. Nat Commun. 2022;13(1):4943. https:\/\/doi.org\/10.1038\/s41467-022-32627-z.","journal-title":"Nat Commun"},{"issue":"4","key":"444_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.molmed.2019.02.004","volume":"25","author":"SL Foo","year":"2019","unstructured":"Foo SL, Yap G, Cui J, Lim LHK. Annexin-a1 - a blessing or a curse in cancer? Trends Mol Med. 2019;25(4):315\u201327. https:\/\/doi.org\/10.1016\/j.molmed.2019.02.004.","journal-title":"Trends Mol Med"},{"issue":"9","key":"444_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092245","volume":"10","author":"TG Ara\u00fajo","year":"2021","unstructured":"Ara\u00fajo TG, Mota STS, Ferreira HSV, Ribeiro MA, Goulart LR, Vecchi L. Annexin a1 as a regulator of immune response in cancer. Cells. 2021;10(9):2245. https:\/\/doi.org\/10.3390\/cells10092245.","journal-title":"Cells"},{"issue":"23","key":"444_CR22","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1002\/cncr.27565","volume":"118","author":"T Cheng","year":"2012","unstructured":"Cheng T, Wu M, Lin J, Lin M, Shun C, Huang H, et al. Annexin a1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor\/extracellular signal-regulated kinase\/integrin beta-1-binding protein 1 pathway. Cancer. 2012;118(23):5757\u201367. https:\/\/doi.org\/10.1002\/cncr.27565.","journal-title":"Cancer"},{"issue":"D1","key":"444_CR23","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, et al. Cell marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47(D1):D721\u20138. https:\/\/doi.org\/10.1093\/nar\/gky900.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"444_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A. CD8(+) t cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22(4):209\u201323. https:\/\/doi.org\/10.1038\/s41577-021-00574-3.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"444_CR25","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/s41416-022-01939-8","volume":"127","author":"K Yu","year":"2022","unstructured":"Yu K, Gu Y, Zhang P, Fang H, Cao Y, Wang J, et al. Intratumoral PD-1(+) CD8(+) t cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. Br J Cancer. 2022;127(9):1709\u201317. https:\/\/doi.org\/10.1038\/s41416-022-01939-8.","journal-title":"Br J Cancer"},{"issue":"1","key":"444_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15413-7","volume":"11","author":"CA Jaeger-Ruckstuhl","year":"2020","unstructured":"Jaeger-Ruckstuhl CA, Hinterbrandner M, H\u00f6pner S, Correnti CE, L\u00fcthi U, Friedli O, et al. TNIK signaling imprints CD8(+) t cell memory formation early after priming. Nat Commun. 2020;11(1):1632. https:\/\/doi.org\/10.1038\/s41467-020-15413-7.","journal-title":"Nat Commun"},{"issue":"10","key":"444_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, Jaccard A, Romero P, Yu Y, Ho P. Metabolic and epigenetic regulation of t-cell exhaustion. Nat Metab. 2020;2(10):1001\u201312. https:\/\/doi.org\/10.1038\/s42255-020-00280-9.","journal-title":"Nat Metab"},{"key":"444_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104207","volume":"83","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Chen L, Chen H, Zhao J, Li K, Sun J, et al. Pan-cancer landscape of t-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy. EBioMedicine. 2022;83:104207. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104207.","journal-title":"EBioMedicine"},{"issue":"4","key":"444_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN. CD8(+) t cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20(4):218\u201332. https:\/\/doi.org\/10.1038\/s41568-019-0235-4.","journal-title":"Nat Rev Cancer"},{"issue":"7749","key":"444_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","volume":"567","author":"X Liu","year":"2019","unstructured":"Liu X, Wang Y, Lu H, Li J, Yan X, Xiao M, et al. Genome-wide analysis identifies NR4a1 as a key mediator of t cell dysfunction. Nature. 2019;567(7749):525\u20139. https:\/\/doi.org\/10.1038\/s41586-019-0979-8.","journal-title":"Nature"},{"issue":"7749","key":"444_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","volume":"567","author":"J Chen","year":"2019","unstructured":"Chen J, L\u00f3pez-Moyado IF, Seo H, Lio CJ, Hempleman LJ, Sekiya T, et al. NR4a transcription factors limit CAR t cell function in solid tumours. Nature. 2019;567(7749):530\u20134. https:\/\/doi.org\/10.1038\/s41586-019-0985-x.","journal-title":"Nature"},{"issue":"1","key":"444_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park J, Hsueh P, Li Z, Ho P. Microenvironment-driven metabolic adaptations guiding CD8(+) t\u00a0cell anti-tumor immunity. Immunity. 2023;56(1):32\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2022.12.008.","journal-title":"Immunity"},{"issue":"31","key":"444_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aap9520","volume":"4","author":"LF Gemta","year":"2019","unstructured":"Gemta LF, Siska PJ, Nelson ME, Gao X, Liu X, Locasale JW, et al. Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8(+) t cells. Sci Immunol. 2019;4(31):eaap9520. https:\/\/doi.org\/10.1126\/sciimmunol.aap9520.","journal-title":"Sci Immunol"},{"issue":"1","key":"444_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.emboj.7600759","volume":"25","author":"IJ White","year":"2006","unstructured":"White IJ, Bailey LM, Aghakhani MR, Moss SE, Futter CE. EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation. EMBO J. 2006;25(1):1\u201312. https:\/\/doi.org\/10.1038\/sj.emboj.7600759.","journal-title":"EMBO J"},{"issue":"2","key":"444_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1006\/bbrc.1994.2255","volume":"203","author":"V Melki","year":"1994","unstructured":"Melki V, Hullin F, Mazarguil H, Fauvel J, Ragab-Thomas JM, Chap H. Annexin i as a potential inhibitor of insulin receptor protein tyrosine kinase. Biochem Biophys Res Commun. 1994;203(2):813\u20139. https:\/\/doi.org\/10.1006\/bbrc.1994.2255.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"444_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neuron.2006.03.044","volume":"50","author":"JC Ar\u00e9valo","year":"2006","unstructured":"Ar\u00e9valo JC, Waite J, Rajagopal R, Beyna M, Chen Z, Lee FS, et al. Cell survival through trk neurotrophin receptors is differentially regulated by ubiquitination. Neuron. 2006;50(4):549\u201359. https:\/\/doi.org\/10.1016\/j.neuron.2006.03.044.","journal-title":"Neuron"},{"issue":"6","key":"444_CR37","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.chembiol.2018.03.010","volume":"25","author":"L Liang","year":"2018","unstructured":"Liang L, Wang H, Shi H, Li Z, Yao H, Bu Z, et al. A designed peptide targets two types of modifications of p53 with anti-cancer activity. Cell Chem Biol. 2018;25(6):761\u201374. https:\/\/doi.org\/10.1016\/j.chembiol.2018.03.010.","journal-title":"Cell Chem Biol"},{"issue":"2","key":"444_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41590-023-01723-7","volume":"25","author":"T Yin","year":"2024","unstructured":"Yin T, Wang G, Wang L, Mudgal P, Wang E, Pan CC, et al. Breaking NGF-TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory t cell protection. Nat Immunol. 2024;25(2):268\u201381. https:\/\/doi.org\/10.1038\/s41590-023-01723-7.","journal-title":"Nat Immunol"},{"issue":"2","key":"444_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088907","volume":"9","author":"J Deng","year":"2014","unstructured":"Deng J, You Q, Gao Y, Yu Q, Zhao P, Zheng Y, et al. Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis. PLoS ONE. 2014;9(2):e88907. https:\/\/doi.org\/10.1371\/journal.pone.0088907.","journal-title":"PLoS ONE"},{"issue":"8","key":"444_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into t cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399. https:\/\/doi.org\/10.1038\/nri3862.","journal-title":"Nat Rev Immunol"},{"key":"444_CR41","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ. UCell: robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J. 2021;19:3796\u20138. https:\/\/doi.org\/10.1016\/j.csbj.2021.06.043.","journal-title":"Comput Struct Biotechnol J"},{"key":"444_CR42","doi-asserted-by":"publisher","unstructured":"Xu K, Yin N, Peng M, Stamatiades EG, Shyu A, Li P, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster t cell immunity. Science (New York, N.Y.). 2021;371(6527):405\u201310. https:\/\/doi.org\/10.1126\/science.abb2683.","DOI":"10.1126\/science.abb2683"},{"key":"444_CR43","doi-asserted-by":"publisher","unstructured":"Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes t helper 1 cell differentiation through an epigenetic mechanism. Science (New York, N.Y.). 2016;354(6311):481\u20134. https:\/\/doi.org\/10.1126\/science.aaf6284.","DOI":"10.1126\/science.aaf6284"},{"key":"444_CR44","doi-asserted-by":"publisher","unstructured":"Dai B, Bailey-Kellogg C. Protein interaction interface region prediction by geometric deep learning. Bioinformatics (Oxford, England). 2021;37(17):2580\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btab154.","DOI":"10.1093\/bioinformatics\/btab154"},{"key":"444_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cbpa.2018.11.003","volume":"48","author":"DG Rattray","year":"2019","unstructured":"Rattray DG, Foster LJ. Dynamics of protein complex components. Curr Opin Chem Biol. 2019;48:81\u20135. https:\/\/doi.org\/10.1016\/j.cbpa.2018.11.003.","journal-title":"Curr Opin Chem Biol"},{"issue":"4","key":"444_CR46","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020;15(4):1484\u2013506. https:\/\/doi.org\/10.1038\/s41596-020-0292-x.","journal-title":"Nat Protoc"},{"issue":"4","key":"444_CR47","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","volume":"21","author":"DS Hong","year":"2020","unstructured":"Hong DS, Dubois SG, Kummar S, Farago AF, Albert CM, Rohrberg KS, et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol. 2020;21(4):531\u201340. https:\/\/doi.org\/10.1016\/S1470-2045(19)30856-3.","journal-title":"Lancet Oncol"},{"issue":"2","key":"444_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40265-018-1044-x","volume":"79","author":"LJ Scott","year":"2019","unstructured":"Scott LJ. Larotrectinib: first global approval. Drugs. 2019;79(2):201\u20136. https:\/\/doi.org\/10.1007\/s40265-018-1044-x.","journal-title":"Drugs"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00444-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00444-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00444-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:34:59Z","timestamp":1775723699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00444-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00444-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of First Affiliated Hospital of Nanjing Medical University (2024-SR-557), and written informed consent was obtained from all participants. All procedures followed were in accordance with the ethical standards approved by Institutional Ethics Committee on human experimentation and with the Helsinki Declaration. Animal study was approved by the Animal Care and Use Committee of Nanjing Medical University (IACUC- 2408069) and was conducted in accordance with the National lnstitutes of Health guide for the care and use of Laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}